Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of BMS-986326 in Participants With Atopic Dermatitis [Phase 1]

View source ↗

Summary

This clinical trial update reports the completion of a Phase 1 study evaluating safety, tolerability, drug levels (pharmacokinetics), and drug effects of BMS-98…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• BMS-986326

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Dermatitis, Atopic | Phase 1 | Status: COMPLETED